Tetsuro Kondo Selected Research

nedaplatin

1/2018	Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
5/2017	Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancer.
12/2015	Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.
9/2014	Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy.
2/2013	Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
4/2012	Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
1/2012	Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
1/2011	Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuro Kondo Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 05/2003
6	Neoplasms (Cancer) 12/2020 - 01/2007
5	Neutropenia 01/2018 - 01/2007
4	Carcinoma (Carcinomatosis) 10/2017 - 01/2011
3	Pneumonia (Pneumonitis) 12/2020 - 02/2010
3	Disease Progression 01/2018 - 02/2010
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2013 - 07/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2015 - 01/2011
2	Febrile Neutropenia 03/2013 - 02/2013
2	Diarrhea 02/2013 - 05/2003
2	Fatigue 02/2013 - 02/2010
2	Thymoma (Thymic Carcinoma) 09/2009 - 01/2007
1	Tuberculosis (Tuberculoses) 06/2021
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Lung Neoplasms (Lung Cancer) 09/2014
1	Hyponatremia 02/2013
1	Oral Hemorrhage 02/2013
1	Vomiting 02/2013
1	Hypotension (Low Blood Pressure) 02/2013
1	Adenocarcinoma of Lung 01/2013
1	Vasculitis (Vasculitides) 01/2013
1	Fever (Fevers) 01/2013
1	Adenocarcinoma 05/2010
1	Hypersensitivity (Allergy) 02/2010
1	Anorexia 02/2010
1	Lymphatic Metastasis 09/2009

Drug/Important Bio-Agent (IBA)

11	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 05/2003
8	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 02/2004
8	nedaplatinIBA 01/2018 - 01/2011
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2017 - 02/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 07/2006
3	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2013
3	Docetaxel (Taxotere)FDA Link 01/2018 - 05/2005
2	AntibodiesIBA 12/2020 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2014
2	Formaldehyde (Formol)FDA Link 10/2017 - 08/2014
2	ParaffinIBA 10/2017 - 08/2014
2	ErbB Receptors (EGF Receptor)IBA 08/2014 - 01/2010
2	Gefitinib (Iressa)FDA Link 01/2012 - 02/2010
2	Methylprednisolone FDA LinkGeneric 09/2009 - 01/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009 - 01/2007
1	pembrolizumabIBA 06/2021
1	Pemetrexed (MTA)FDA Link 12/2019
1	Peptides (Polypeptides)IBA 09/2014
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 09/2014
1	TegafurIBA 03/2013
1	CreatinineIBA 03/2013
1	amrubicinIBA 03/2013
1	UracilIBA 03/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2010
1	Anaplastic Lymphoma KinaseIBA 09/2010
1	Biological ProductsIBA 05/2010
1	Alanine Transaminase (SGPT)IBA 02/2010
1	Gemcitabine FDA Link 07/2007
1	PlatinumIBA 07/2007
1	Carboplatin (JM8)FDA LinkGeneric 07/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2004
1	beta-glucuronidase inhibitorIBA 05/2003
1	hange-shashintoIBA 05/2003
1	baicalinIBA 05/2003

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2018 - 07/2006
8	Therapeutics 06/2021 - 01/2007
6	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 02/2004
4	Aftercare (After-Treatment) 06/2021 - 07/2007
3	Radiotherapy 05/2017 - 01/2007
1	Immunotherapy 12/2020
1	Adjuvant Chemotherapy 01/2018
1	Molecular Targeted Therapy 10/2017
1	Operative Surgical Procedures 08/2012
1	Thymectomy 09/2009
1	Metastasectomy 09/2009
1	Pneumonectomy (Lung Volume Reduction) 09/2009
1	Induction Chemotherapy 09/2009
1	Kampo Medicine (Kampo) 05/2003